The first-line treatment for unstable tachycardia is synchronized cardioversion, an electrical shock delivered to the heart that is timed to restore a normal rhythm. When a fast heart rate is causing dangerous symptoms like low blood pressure, chest pain, or confusion, synchronized cardioversion is the immediate priority because medications take too long to work and the patient’s condition can deteriorate rapidly.
What Makes a Tachycardia “Unstable”
A fast heart rate on its own doesn’t necessarily mean someone is unstable. The distinction matters because it completely changes the treatment approach. A tachycardia becomes unstable when the heart is beating so fast that it can’t pump blood effectively, starving organs of oxygen. This tends to happen more often when the heart rate exceeds 150 beats per minute, though it can occur at lower rates in people with underlying heart disease.
The signs that clinicians look for include:
- Low blood pressure (hypotension), sometimes progressing to full shock
- Altered mental status, such as confusion, drowsiness, or loss of consciousness
- Chest pain, indicating the heart muscle itself isn’t getting enough blood
- Shortness of breath or low oxygen levels
- Signs of poor organ perfusion, like pale or clammy skin
If any of these signs are present alongside a rapid heart rate, the tachycardia is considered unstable and requires immediate electrical treatment. A patient who is tachycardic but alert, comfortable, and maintaining normal blood pressure is treated differently, usually with medications or monitoring first.
How Synchronized Cardioversion Works
Synchronized cardioversion delivers a controlled electrical shock through pads placed on the chest. The key word is “synchronized.” The machine reads the heart’s electrical activity on a monitor and times the shock to land during a specific part of the heartbeat cycle, the moment the heart’s main pumping chambers are contracting (the R-wave on an EKG). This timing is critical because delivering electricity during the wrong phase of the heartbeat, specifically during the recovery period between beats, can trigger ventricular fibrillation, a chaotic rhythm where the heart quivers instead of pumping. That would turn a bad situation into cardiac arrest.
The shock essentially resets the heart’s electrical system. By briefly depolarizing the heart muscle all at once, it interrupts the abnormal electrical circuit causing the rapid rate and gives the heart’s natural pacemaker a chance to take over with a normal rhythm.
Energy Levels and What to Expect
The electrical energy used for cardioversion ranges from 50 to 200 joules, depending on the type of rhythm being treated. The general approach is to start at the lowest effective dose, typically 50 joules, and double the energy if the first shock doesn’t work. After three unsuccessful attempts, the maximum of 200 joules may be used.
The 2025 American Heart Association guidelines make one notable exception: for atrial fibrillation and atrial flutter with rapid ventricular response, higher first-shock energy settings of 200 joules or more are preferred over lower starting doses, since these rhythms tend to be more resistant to lower energy levels.
For children, the energy is calculated by body weight at 1 to 2 joules per kilogram. Smaller paddles are used for children weighing 10 kilograms (about 22 pounds) or less, while standard adult paddles are appropriate for larger children.
Sedation Before the Shock
If the patient is still conscious, which many unstable tachycardia patients are, sedation is given before the shock. Cardioversion is painful, and delivering it to an awake person without sedation would be distressing. The goal is brief, light sedation that wears off quickly afterward, not deep anesthesia.
The most commonly used sedation options are propofol, etomidate, and midazolam. For most patients, propofol is the preferred choice because it produces rapid sedation and wears off quickly, allowing a fast recovery. The exception is elderly patients or those with significant heart disease, where etomidate paired with a pain reliever tends to maintain more stable blood pressure during the procedure. In truly life-threatening emergencies where the patient is about to lose consciousness or is in full shock, the shock may be delivered without waiting for sedation.
When the First Shock Doesn’t Work
Synchronized cardioversion is effective for most unstable tachycardias, but some cases are refractory. When repeated shocks at escalating energy levels fail to convert the rhythm, medications become the next step. The two drugs most commonly used in this scenario are amiodarone and procainamide, both of which work by stabilizing the heart’s electrical activity and slowing conduction through abnormal pathways.
These medications are given intravenously and take effect over minutes to hours, which is why they aren’t suitable as the first option when someone is hemodynamically crashing. They serve as a backup when the electrical approach hasn’t restored a normal rhythm, or as a bridge to prevent the abnormal rhythm from returning after a successful shock.
Why Speed Matters
The urgency of synchronized cardioversion comes down to a simple equation: every minute the heart spends in an unstable rapid rhythm, organs are being deprived of adequate blood flow. The brain is especially vulnerable, which is why confusion and altered consciousness are such important warning signs. Prolonged unstable tachycardia can also push the heart into frank heart failure, particularly if the rapid rate has been sustained for hours or days before treatment.
This is why the 2025 AHA guidelines emphasize rapid assessment of clinical stability as the first step in managing any tachycardia. The entire decision tree hinges on one question: is this patient stable or unstable? If unstable, the answer is synchronized cardioversion, performed as quickly as the team can attach the pads and, ideally, sedate the patient.